Abstract: The present invention relates to a medicament for the treatment and/or prevention of cancer, the medicament being characterized by comprising an antibody having an immunological reactivity with CAPRIN-1 protein or a fragment of the antibody and an MAPK pathway inhibitor which are combined with each other in a blended or separated form.
| # | Name | Date |
|---|---|---|
| 1 | 202417009762-STATEMENT OF UNDERTAKING (FORM 3) [13-02-2024(online)].pdf | 2024-02-13 |
| 3 | 202417009762-Sequence Listing in txt [13-02-2024(online)].txt | 2024-02-13 |
| 4 | 202417009762-Sequence Listing in PDF [13-02-2024(online)].pdf | 2024-02-13 |
| 5 | 202417009762-PROOF OF RIGHT [13-02-2024(online)].pdf | 2024-02-13 |
| 6 | 202417009762-POWER OF AUTHORITY [13-02-2024(online)].pdf | 2024-02-13 |
| 7 | 202417009762-FORM 1 [13-02-2024(online)].pdf | 2024-02-13 |
| 8 | 202417009762-FIGURE OF ABSTRACT [13-02-2024(online)].pdf | 2024-02-13 |
| 9 | 202417009762-DRAWINGS [13-02-2024(online)].pdf | 2024-02-13 |
| 10 | 202417009762-DECLARATION OF INVENTORSHIP (FORM 5) [13-02-2024(online)].pdf | 2024-02-13 |
| 11 | 202417009762-COMPLETE SPECIFICATION [13-02-2024(online)].pdf | 2024-02-13 |
| 12 | 202417009762-certified copy of translation [14-02-2024(online)].pdf | 2024-02-14 |
| 13 | 202417009762-FORM 3 [10-08-2024(online)].pdf | 2024-08-10 |
| 14 | 202417009762-MARKED COPIES OF AMENDEMENTS [18-07-2025(online)].pdf | 2025-07-18 |
| 15 | 202417009762-FORM 13 [18-07-2025(online)].pdf | 2025-07-18 |
| 16 | 202417009762-AMMENDED DOCUMENTS [18-07-2025(online)].pdf | 2025-07-18 |
| 17 | 202417009762-FORM 18 [21-07-2025(online)].pdf | 2025-07-21 |